Navigation Links
Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review
Date:6/19/2013

Lexington, Mass. (PRWEB) June 19, 2013

Imprivata®, a leading global provider of healthcare IT security solutions, today announced that Imprivata OneSign® leads the single sign-on (SSO) category in the KLAS® 2013 Mid-Term Performance Review: Software & Services report. CIOs and other healthcare executives iwere nterviewed by KLAS laud Imprivata on the superior performance of its products and the quality of its customer service and support, and they indicate that Imprivata is integral to their long-term healthcare IT strategy.

“Imprivata is a strategic partner. The SSO product used in conjunction with smooth roaming creates an environment that is both efficient and highly valued by our users. Imprivata enables No Click Access™ to clinical systems and patient information that delivers both security and convenience that clinicians need to better focus on patient care,” said Bruce Hall, CIO of Augusta Health, a 255-bed hospital in Fisherville, Va. “In addition, Imprivata understands the evolving healthcare IT landscape. We expect Imprivata will remain central to our healthcare IT strategy over the long term.”

The KLAS 2013 Mid-Term Performance Review: Software & Services report profiles hundreds of software and services vendors, providing a detailed look at the performance of each company's product line. The report aggregates performance data gathered over the past 12 months. The findings represent the voice of thousands of providers sharing their candid experience with various healthcare technology and vendors. Imprivata OneSign received a score of 88.4, building on the company’s momentum from 2012 when it was recognized as the SSO category leader in the KLAS 2012 Top 20 Best in KLAS Awards report.

“KLAS rankings are derived directly from customer input, so our consistently high scores serve as strong independent validation of Imprivata’s products, customer service and strategic importance,” said Ed Gaudet, chief marketing officer of Imprivata. “Imprivata also has the highest U.S. market share among SSO providers, according to HIMSS Analytics data, which supports feedback that we regularly receive from customers—Imprivata is the most widely-used application in hospitals after the electronic medical records system. Imprivata is simplifying healthcare IT to enable our customers with better focus on patient care.”

About Imprivata
Imprivata, the leader in healthcare IT security, enables secure access and collaboration for two million healthcare users worldwide. As the #1 independent provider of single sign-on and access management solutions for healthcare and other regulated industries, Imprivata OneSign® Single Sign-On is exclusively endorsed by the American Hospital Association (AHA) and recognized by Gartner and KLAS. Imprivata Cortext™ is the leading free HIPAA compliant text messaging solution for healthcare. Headquartered in Lexington, Massachusetts, Imprivata serves 1,300 hospitals in partnership with over 200 EMR and technology infrastructure vendors around the world. For more information, please visit http://www.imprivata.com.

All Imprivata products are trademarks of Imprivata, Inc. in the USA and other countries. All other product or company names mentioned are the property of their respective owners.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10848144.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Imprivata is the Most Widely Selected Single Sign-On Solution by U.S. MEDITECH Customers According to HIMSS Analytics
2. MEDIA ALERT: Imprivata and Dell Wyse to Discuss Benefits of Desktop Virtualization and Single Sign-On in Healthcare at Citrix Synergy
3. Upstart Bachelorista Inc. Releases Tell-All Playbook For Single Women
4. Johns Hopkins surgeons among the first in the country to perform a robotic single-site hysterectomy
5. Talk Therapy Can Ease Depression, But No Single Type Deemed Best
6. LAPD Singles Out Narconon Drug Prevention and Education for Special Commendation
7. Northern Westchester Hospital Surgeon Reaches New Single-Incision Robot-Assisted Gallbladder Removal Surgery Milestone
8. Unique group for single fathers due to cancer offers support
9. Single Leg Deadlift Exercise Video Revealed By Bodyweight Torch
10. Single Concussion May Lead to Lasting Brain Damage
11. Single concussion may cause lasting brain damage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... franchises from across the country gathered at the La Valencia Hotel in San ... PROSHRED Chicago was named the year’s most outstanding franchise, walking away with ...
(Date:2/5/2016)... ... 05, 2016 , ... Pivot Point Consulting, a leading national ... & Services for HIT Implementation Support & Staffing report with an outstanding score ... by healthcare executives, managers and clinicians representing over 4,500 hospitals and 2,500 clinics. ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Colorize ... from on one drop zone to the next using Colorize's dynamic moving camera. Colorize ... project. This package includes a 3D slideshow environment with 1 to 5 focus points ...
(Date:2/5/2016)... ... 05, 2016 , ... Calls Blacklist has just been updated by mobile app ... the developer has fixed known bugs within the app. Calls Blacklist allows its users ... not consuming any of their device’s battery power or memory. It provides a powerful ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Feb. 4, 2016  SciClone Pharmaceuticals, Inc. (NASDAQ: ... has entered into a settlement agreement with the ... resolving the SEC,s investigation into possible violations of ... terms of the settlement agreement, SciClone has agreed ... disgorgement, pre-judgment interest and a penalty.  This payment ...
(Date:2/4/2016)... -- Global Immunology Market to 2022 - Large ... growth Summary Immune-mediated inflammatory diseases are ... affect 5–7% of western populations. Although they are ... key patient demographics, they are pathophysiologically linked, being ... inappropriate immune response. Generally, disease-modifying anti-rheumatic drugs, a ...
(Date:2/4/2016)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... treat life-threatening diseases, today announced results for the ... 2015. --> --> ... our last quarterly call, we strategically advanced pre-clinical ... to establish the Aethlon Hemopurifier® as a leading ...
Breaking Medicine Technology: